Cardiac Monitoring Company to Pay $6.4 Million for Alleged Overbilling of Government Health Care Programs
BioTelemetry Inc., a heart monitoring company headquartered in Malvern, Pennsylvania, has agreed to pay $6.4 million to resolve allegations made under the False Claims Act (FCA) that its subsidiary, CardioNet, overbilled Medicare and other federal health programs for Mobile Cardiac Outpatient Telemetry (MCOT) services when those services were not reasonable or medically necessary, the Justice Department announced today.
- Date:March 19, 2015
- Agency:U.S. Department of Justice
- Criminal and Civil Actions